Y-mAbs Therapeutics
YMAB
YMAB
59 hedge funds and large institutions have $251M invested in Y-mAbs Therapeutics in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+14
Holders Change %
+31.11%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
25
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
$26.4M |
2 |
AG
Artal Group
Luxembourg
|
$9.15M |
3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$22.9M |
4 |
State Street
Boston,
Massachusetts
|
$7.37M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
$11.2M |